Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Board Meeting | 10 February 2026

· NSE 🟡 Notable ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Apollo Hospitals Enterprise Limited reported Q3 FY2026 consolidated revenue of ₹6,477 crores with 17% YoY growth and PAT of ₹502 crores (up 35% YoY). The Board approved an interim dividend of ₹10 per share (200% of face value). Nine-month YTD revenue reached ₹18,623 crores (15% growth) with PAT of ₹1,412 crores (34% growth). Healthcare Services revenue grew 14% with strong 24.8% EBITDA margins. Apollo 24/7 digital platform achieved ₹525 crores GMV with 28% growth. The company operates 8,072 hospital beds and 7,113 pharmacy stores. A composite demerger scheme involving pharmacy distribution and digital health into Apollo Healthtech Limited awaits NCLT approval.

📄 View Original Announcement (PDF)

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

📡 Get AI alerts when APOLLOHOSP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APOLLOHOSP — Free

📊 More APOLLOHOSP filings

See all APOLLOHOSP filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APOLLOHOSP files new disclosures

Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APOLLOHOSP — Free

Free account · 2 AI queries/day